These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Differential activation of mTOR signaling by contractile activity in skeletal muscle. Parkington JD; Siebert AP; LeBrasseur NK; Fielding RA Am J Physiol Regul Integr Comp Physiol; 2003 Nov; 285(5):R1086-90. PubMed ID: 12881204 [TBL] [Abstract][Full Text] [Related]
8. Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK. White JP; Puppa MJ; Gao S; Sato S; Welle SL; Carson JA Am J Physiol Endocrinol Metab; 2013 May; 304(10):E1042-52. PubMed ID: 23531613 [TBL] [Abstract][Full Text] [Related]
9. Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia. Khamoui AV; Park BS; Kim DH; Yeh MC; Oh SL; Elam ML; Jo E; Arjmandi BH; Salazar G; Grant SC; Contreras RJ; Lee WJ; Kim JS Metabolism; 2016 May; 65(5):685-698. PubMed ID: 27085776 [TBL] [Abstract][Full Text] [Related]
10. The regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse. White JP; Baynes JW; Welle SL; Kostek MC; Matesic LE; Sato S; Carson JA PLoS One; 2011; 6(9):e24650. PubMed ID: 21949739 [TBL] [Abstract][Full Text] [Related]
11. Skeletal muscle function during the progression of cancer cachexia in the male Apc VanderVeen BN; Hardee JP; Fix DK; Carson JA J Appl Physiol (1985); 2018 Mar; 124(3):684-695. PubMed ID: 29122966 [TBL] [Abstract][Full Text] [Related]
12. Systemic IL-6 regulation of eccentric contraction-induced muscle protein synthesis. Hardee JP; Fix DK; Wang X; Goldsmith EC; Koh HJ; Carson JA Am J Physiol Cell Physiol; 2018 Jul; 315(1):C91-C103. PubMed ID: 29641213 [TBL] [Abstract][Full Text] [Related]
13. Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice. Baltgalvis KA; Berger FG; Peña MM; Mark Davis J; White JP; Carson JA J Appl Physiol (1985); 2010 Oct; 109(4):1155-61. PubMed ID: 20651218 [TBL] [Abstract][Full Text] [Related]
14. Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc ( Min/+ ) mouse. Baltgalvis KA; Berger FG; Peña MM; Davis JM; White JP; Carson JA Pflugers Arch; 2009 Mar; 457(5):989-1001. PubMed ID: 18712412 [TBL] [Abstract][Full Text] [Related]
15. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype. Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129 [TBL] [Abstract][Full Text] [Related]
16. Sex differences in the relationship of IL-6 signaling to cancer cachexia progression. Hetzler KL; Hardee JP; Puppa MJ; Narsale AA; Sato S; Davis JM; Carson JA Biochim Biophys Acta; 2015 May; 1852(5):816-25. PubMed ID: 25555992 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological strategies in lung cancer-induced cachexia: effects on muscle proteolysis, autophagy, structure, and weakness. Chacon-Cabrera A; Fermoselle C; Urtreger AJ; Mateu-Jimenez M; Diament MJ; de Kier Joffé ED; Sandri M; Barreiro E J Cell Physiol; 2014 Nov; 229(11):1660-72. PubMed ID: 24615622 [TBL] [Abstract][Full Text] [Related]
18. Myofiber degeneration/regeneration is induced in the cachectic ApcMin/+ mouse. Mehl KA; Davis JM; Berger FG; Carson JA J Appl Physiol (1985); 2005 Dec; 99(6):2379-87. PubMed ID: 16288100 [TBL] [Abstract][Full Text] [Related]
20. Development of an UPLC mass spectrometry method for measurement of myofibrillar protein synthesis: application to analysis of murine muscles during cancer cachexia. Lima M; Sato S; Enos RT; Baynes JW; Carson JA J Appl Physiol (1985); 2013 Mar; 114(6):824-8. PubMed ID: 23329823 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]